Logan Capital Management’s Pfizer PFE Stock Holding History

Logan Capital Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$12.6M	Buy	+450,453	New	+$12M	0.55%	48

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Logan Capital Management's PFE Position: Q1 2026 in Review

Logan Capital Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 405,555 shares — an estimated $10.8M sold.

Logan Capital Management first reported a position in PFE in Q2 2013 and held it in 51 quarters. The position peaked at $27.2M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Logan Capital Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
Logan Capital Management sold 405,555 Pfizer shares in Q1 2026, an estimated $10.8M.
Logan Capital Management first reported a position in Pfizer in Q2 2013 and held it in 51 quarters.
Logan Capital Management's Pfizer position peaked at $27.2M in Q4 2021.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Logan Capital Management's 13F filing for Q1 2026, filed 8 May 2026.